Semi-Annual Consolidated Balance Sheet

Carna Biosciences, Inc. - Filing #7568781

Concept As at
2023-03-31
As at
2022-12-31
Semi-annual consolidated balance sheet
Balance sheet
Assets
Current assets
Cash and deposits
4,082,018,000 JPY
3,379,048,000 JPY
Other
410,353,000 JPY
424,308,000 JPY
Current assets
4,794,361,000 JPY
4,104,316,000 JPY
Non-current assets
Property, plant and equipment
96,022,000 JPY
100,231,000 JPY
Property, plant and equipment
Intangible assets
Intangible assets
1,709,000 JPY
1,915,000 JPY
Investments and other assets
53,168,000 JPY
59,990,000 JPY
Investments and other assets
Non-current assets
150,900,000 JPY
162,137,000 JPY
Assets
4,945,261,000 JPY
4,266,453,000 JPY
Liabilities
Current liabilities
Income taxes payable
15,667,000 JPY
30,664,000 JPY
Other
11,541,000 JPY
16,654,000 JPY
Current liabilities
389,360,000 JPY
436,407,000 JPY
Non-current liabilities
Long-term borrowings
118,405,000 JPY
148,402,000 JPY
Asset retirement obligations
38,194,000 JPY
38,040,000 JPY
Other
1,459,000 JPY
1,759,000 JPY
Non-current liabilities
158,059,000 JPY
188,201,000 JPY
Liabilities
547,420,000 JPY
624,609,000 JPY
Net assets
Share capital
2,023,976,000 JPY
1,382,246,000 JPY
Shareholders' equity
Capital surplus
5,775,186,000 JPY
5,133,456,000 JPY
Retained earnings
-3,441,701,000 JPY
-2,922,490,000 JPY
Treasury shares
-222,000 JPY
-222,000 JPY
Shareholders' equity
4,357,238,000 JPY
3,592,988,000 JPY
Valuation and translation adjustments
Valuation difference on available-for-sale securities
-2,474,000 JPY
-2,373,000 JPY
Deferred gains or losses on hedges
JPY
615,000 JPY
Foreign currency translation adjustment
34,874,000 JPY
33,225,000 JPY
Valuation and translation adjustments
32,400,000 JPY
31,467,000 JPY
Share acquisition rights
8,202,000 JPY
17,388,000 JPY
Net assets
4,397,841,000 JPY
3,641,844,000 JPY
Liabilities and net assets
4,945,261,000 JPY
4,266,453,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.